GDC0834(1133432-49-1)
- Name: GDC0834
- Synonyms:GDC-0834;N-(3-(6-(4-((2R)-1,4-dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide;(R)-N-(3-(6-(4-(1,4-Dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide;
- Molecular Formula:C33H36N6O3S
- Molecular Weight:596.753
- CAS Registry Number:1133432-49-1
- EINECS:
- Melting Point:
- Water Solubility:
China (Mainland)] 
Premium
United States] 
Premium
Other Product
- 1087740-50-8/2,6-Diazaspiro[3.3]heptane, (Hydrochloride), hydrate (1:2:2)
- 1276666-12-6/4-((2-aminoethyl)(5-chlorobenzo[d]oxazol-2-yl)amino)butan-2-one (dimethanesulfonate)
- 915385-81-8/ABC294640
- 1415560-69-8/PF 02341066 hydrochloride
- 1173900-38-3/(S)-methyl 2-(1-(7-methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoate
- 1380575-43-8/LDK-378 dihydrochloride
- 23491-55-6/Hoechst 33258 analog 5
- 23554-98-5/Hoechst 33258 analog 3
- 1131042-11-9/GSK1720070
- 897732-93-3/JNJ-38431055
- 255374-90-4/WX-UK1
- 701909-57-1/XEN-2174
- 1095173-27-5/PF 04449913
- 1207358-59-5/mTOR inhibitor
- 957209-68-6/NVP-QAV-572
- 1269440-17-6/Encorafenib (LGX818)
- 1251533-99-9/N-(4-chlorophenyl)-1-(pyrimidin-2-yl)-1H-pyrrole-2-sulfonamide
- 1305115-80-3/PF-04957325
- 1085703-32-7/VITAMIN CK3
- 1133432-49-1/GDC0834
- 882759-86-6/Alanine, N,N'-[[5-[2-amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]pho sphinylidene]bis[2-methyl-, diethyl ester, monomethanesulfonate
- 191801-19-1/BAL-9602
- 945771-74-4/BNC105
- 942149-56-6/DM-CHOC-PEN
- 603288-22-8/LY2090314
- 744208-75-1/NA-808
- 891495-88-8/SCH900776 raemic mixture
- 1228237-57-7/ARQ 736
- 1233948-35-0/ELR-510444
- 308145-19-9/2-Butene-1,4-diamine, N,N'-bis[3-(ethylamino)propyl]-, (2Z)-